New Lupus Treatment Option in Spain
What Is Lupus?
Systemic lupus erythematosus (SLE) is a long‑term autoimmune disease. The body’s defense system mistakenly attacks its own tissues, which can cause fatigue, joint pain, skin rashes, fever, and sometimes problems with organs like the kidneys or heart. Lupus mostly affects women and can show up in flare‑ups that make everyday activities harder.
How the New Medicine Works
The drug anifrolumab (brand name Saphnelo) targets a specific protein involved in the immune overreaction seen in lupus. By blocking that protein, it helps calm the immune system and reduces disease activity. Until now, patients received it through an intravenous drip at a hospital or clinic.
From Hospital Shots to Home Pens
AstraZeneca has launched a subcutaneous formulation of Saphnelo in Spain. This version comes in a pre‑filled pen that delivers a 120 mg dose. After a healthcare professional checks that it’s suitable and gives the patient (or a caregiver) training, the injection can be done once a week at home.
What the Pen Looks Like
The pen is similar to those used for other injectable medicines: a small device with a needle hidden inside. You press a button, the medicine flows under the skin, and the process takes just a few seconds.
Why This Matters for Daily Life
Going to the hospital for regular infusions can disrupt school, work, and social plans. The home‑injection option:
- Reduces the need for frequent trips to a medical center.
- Gives patients more control over when they take their medicine.
- Lessens the feeling of being “dependent” on a clinic schedule.
Staying on Track with Medication
Sticking to the treatment plan is crucial. Skipping doses can lead to more flare‑ups and increase the risk of lasting organ damage. Studies show that anywhere from 43% to 75% of lupus patients sometimes miss doses. A simpler, at‑home method can help improve adherence.
Tips for Using the Pen Safely
- Wash your hands before handling the pen.
- Choose a clean, dry spot on the thigh, abdomen, or upper arm.
- Follow the step‑by‑step instructions given by your nurse or doctor.
- Dispose of the used pen in a sharps container.
- Keep track of the day you inject so you don’t miss a dose.
Looking Ahead
The subcutaneous Saphnelo is not a brand‑new drug; it’s the same medicine that has been available by IV infusion since 2021, just delivered in a more user‑friendly way. For many teens and adults living with lupus, this change could mean fewer hospital visits, more flexibility, and a better quality of life.
Conclusion
The arrival of a pre‑filled pen for anifrolumab in Spain offers a promising step forward for people with moderate to severe lupus. By allowing weekly self‑injection at home, it aims to reduce hospital dependence, improve treatment adherence, and let patients focus more on school, hobbies, and time with friends—while still keeping their disease under control.
Images Credit: www.diariodeibiza.es